1. Reliability and validity of internalized stigmatization scale in psoriasis
- Author
-
Aslı Bilgiç Temel, G. Özge Baysal, Ayşe Akman Karakaş, Yeşim Şenol, and Erkan Alpsoy
- Subjects
validity ,reliability ,Scale (ratio) ,business.industry ,Dermatology ,internalized stigmatization ,lcsh:RL1-803 ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:RC870-923 ,Reliability engineering ,stigmatization ,lcsh:Dermatology ,Medicine ,Psoriasis ,business ,Reliability (statistics) - Abstract
Backround and design. Internalized stigma involves endorsing negative feelings and beliefs such as insignificance, shame and withdrawal triggered by applying these negative stereotypes to one self. Internalized Stigma Scale has not been applied to psoriasis patients. We aimed to evaluate the reliability and validity of Internalized Stigma Scale in psoriasis patients. Materials and Methods. 100 consecutive, volunteer psoriasis patients (48 female, 52 male; aged, 40.59±15.44 years) were enrolled in the study. PASI and BSA were evaluated by physician (A.B.). Patients responded contemporaneously to Psoriasis Internalized Stigma Scale (PISS), DQoL, and Perceived Health Status (PHS), single-item self-rated general health question, of which Likert scores 1, 2, and 3 were classified as “from fair to very poor”, and 4, 5 as “good”. Results. Cronbach's alpha coefficient of PISS subscales was 0.83 for alienation, 0.70 for stereotype endorsement, 0.70 for perceived discrimination, 0.84 for social withdrawal and 0.68 for stigma resistance. The same value was 0.89 for the total scale. PISS and DQoL scores mean values were 58.8±12.6 and 10.0±9.4, respectively. PISS was significantly correlated with the patients' DQoL scores (r=,726, p=0,001). PISS was also significantly correlated with disease duration (r=,209, p=0,047). There was no any significant relationship between PASI or BSA and PISS. Mean DQoL scores in patients reporting their PHS as “from fair to very poor” and “good” were 12.1±7.3 and 5.0±4.3, respectively. Mean values of PISS in patients reporting their PHS as “from fair to very poor” was significantly increased compared with patients reporting their PHS as “good” (p=0.001). Conclusion. PISS can be used as a reliable and valid tool in assesing internalized stigmatization in psoriasis patients. Our results indicate a high level of stigmatization in psoriasis patients. Low DQoL scores show a correlation with increased levels of internalized stigmatization. PHS is also worse in patients with Low DQoL scores.
- Published
- 2015